PFIZER Income Statement - TTM - Pfizer Limited

Income Statement (TTM)

Pfizer Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	21,505	22,058	22,404	24,728	25,137	25,961	26,110	24,571	24,583	24,041	24,248	23,632	23,010	22,192	21,932	22,247	22,380	22,361	22,814	23,215
Change (%)		2.57	1.57	10.38	1.65	3.28	0.57	-5.90	0.05	-2.20	0.86	-2.54	-2.63	-3.55	-1.17	1.44	0.60	-0.09	2.02	1.76
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	7,874	7,991	8,028	8,997	9,194	9,592	9,529	8,942	8,874	8,522	8,778	8,779	8,580	8,234	7,983	7,774	7,890	8,030	8,158	8,264
Change (%)		1.49	0.46	12.07	2.18	4.33	-0.66	-6.16	-0.76	-3.96	3.01	0.00	-2.26	-4.04	-3.05	-2.62	1.50	1.77	1.59	1.29
% of Revenue	36.61	36.23	35.83	36.38	36.57	36.95	36.49	36.39	36.10	35.45	36.20	37.15	37.29	37.10	36.40	34.94	35.25	35.91	35.76	35.59

Gross Operating Profit	13,631	14,067	14,376	15,731	15,943	16,369	16,581	15,629	15,709	15,519	15,469	14,854	14,429	13,958	13,949	14,473	14,490	14,330	14,655	14,952
Change (%)		3.19	2.20	9.43	1.35	2.67	1.29	-5.75	0.52	-1.21	-0.32	-3.98	-2.86	-3.27	-0.06	3.76	0.12	-1.10	2.27	2.02
% of Revenue	63.39	63.77	64.17	63.62	63.43	63.05	63.51	63.61	63.90	64.55	63.80	62.85	62.71	62.90	63.60	65.06	64.75	64.09	64.24	64.41

SG&A	4,514	4,555	4,266	4,353	4,564	4,720	4,784	4,762	4,514	4,334	3,935	3,948	4,021	3,998	4,337	3,456	4,425	4,494	4,289	4,333
Change (%)		0.92	-6.35	2.04	4.84	3.42	1.36	-0.45	-5.21	-4.00	-9.21	0.34	1.85	-0.58	8.49	-20.31	28.03	1.56	-4.58	1.04
% of Revenue	20.99	20.65	19.04	17.60	18.16	18.18	18.32	19.38	18.36	18.03	16.23	16.71	17.48	18.01	19.78	15.54	19.77	20.10	18.80	18.67

R&D
Change (%)
% of Revenue

OpEx	16,148	16,093	16,358	17,636	18,179	19,019	18,888	18,259	17,838	17,206	17,202	17,288	17,048	16,651	16,162	15,839	15,862	15,880	16,002	16,076
Change (%)		-0.34	1.65	7.81	3.08	4.62	-0.69	-3.33	-2.31	-3.55	-0.02	0.50	-1.39	-2.33	-2.94	-1.99	0.15	0.12	0.76	0.47
% of Revenue	75.09	72.96	73.02	71.32	72.32	73.26	72.34	74.31	72.56	71.57	70.94	73.15	74.09	75.03	73.69	71.20	70.88	71.02	70.14	69.25

Operating Income	5,357	5,965	6,045	7,092	6,958	6,942	7,222	6,312	6,745	6,836	7,046	6,344	5,962	5,540	5,770	6,408	6,518	6,480	6,812	7,139
Change (%)		11.35	1.34	17.32	-1.90	-0.22	4.03	-12.61	6.86	1.35	3.07	-9.96	-6.03	-7.06	4.15	11.04	1.73	-0.58	5.12	4.80
% of Revenue	24.91	27.04	26.98	28.68	27.68	26.74	27.66	25.69	27.44	28.43	29.06	26.85	25.91	24.97	26.31	28.80	29.12	28.98	29.86	30.75

Interest Expense	-138	-152	-151	-144	-118	-102	-105	-119	-130	-147	-134	-126	-120	-110	-154	-146	-140	-127	-84	-96
Change (%)		10.07	-0.53	-5.03	-17.42	-14.09	3.05	13.25	9.85	12.72	-8.97	-5.75	-5.15	-8.19	40.22	-4.93	-4.30	-9.63	-33.62	13.56
% of Revenue	-0.64	-0.69	-0.67	-0.58	-0.47	-0.39	-0.40	-0.48	-0.53	-0.61	-0.55	-0.53	-0.52	-0.50	-0.70	-0.66	-0.63	-0.57	-0.37	-0.41

Net Income	4,979	5,001	4,976	5,731	5,846	5,873	6,126	4,452	6,133	6,201	6,239	6,849	5,228	5,021	5,513	6,085	6,179	6,155	7,676	8,086
Change (%)		0.44	-0.49	15.16	2.02	0.46	4.30	-27.32	37.76	1.10	0.62	9.77	-23.67	-3.96	9.80	10.37	1.54	-0.39	24.71	5.35
% of Revenue	23.15	22.67	22.21	23.17	23.26	22.62	23.46	18.12	24.95	25.79	25.73	28.98	22.72	22.63	25.14	27.35	27.61	27.53	33.65	34.83

Source: Capital IQ

Pfizer Limited - Income Statement (TTM)

Income Statement (TTM)

Other Listings